Clinical Trial Update: Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

View source ↗

Summary

This completed trial evaluated the usability and tolerability of the Norditropin NordiFlex injection device in children with growth hormone deficiency who had n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Fetal Growth Restriction
• Growth Hormone Deficiency in Children
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Status: COMPLETED